Event-Driven Stocks

Envision Healthcare Corp

Healthcare · Services-Offices & Clinics of Doctors of Medicine · SEC filings ↗ · Compare ⊕

Signs4 good1 warningdetails ↓

Financials

SEC XBRL · annual
 FY17FY16FY15FY14
Revenue$1.88B$724.7M$2.57B$1.62B
Operating income$189.2M$369.9M$617.5M$394.4M
Net income−$228.0M−$18.6M$163.0M$53.7M
Total assets$16.57B$16.71B$6.50B
Total liabilities
Equity$6.53B$6.73B$2.29B
EPS (diluted)$-3.84$0.53$3.16$1.24
Shares out.117.4M117.5M54.3M39.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2017
Operating margin
10.1%
Net margin
−12.1%
Return on equity
−3.5%
Return on assets
−1.4%
Return on capital (ROCE)
1.2%
Liabilities / assets
Debt / equity
Book value / share
$55.59
Revenue growth (YoY)
159.2%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2017
Accruals / assets
6.2%clean
Piotroski F-Score
5/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
75
/ 100
Profitability 40Growth 100Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

1 warning4 good
  • Reported a net loss
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Insider transactions

SEC Form 4 · most recent
0 acquisitions12 disposalsnet 280,448 shares · last 12
InsiderDateTypeSharesPrice
Kenneth Zongor EOfficer — Chief Accounting OfficerOct 11, 2018D12,117$46.00
Witty Karey LOfficer — Chief Operating OfficerOct 11, 2018D21,237$46.00
Wilson Craig A.Officer — General Counsel &amp; SecretaryOct 11, 2018D24,441$46.00
Solomon Patrick BlairOfficer — Chief Strategy OfficerOct 11, 2018D32,889$46.00
Smith Michael LDirectorAug 7, 2018Gift1,503
Shelton James DDirectorOct 11, 2018D13,553$46.00
Sanger William ADirectorOct 11, 2018D70,862$46.00
Riggs Leonard M JrDirectorOct 11, 2018D19,359$46.00
Miller Cynthia SDirectorOct 11, 2018D23,392$46.00
Lavender Kevin PDirectorOct 11, 2018D19,321$46.00
Jacobs Joey ADirectorOct 11, 2018D17,472$46.00
Jackson Brian L.Officer — President Physician ServicesOct 11, 2018D24,302$46.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.